ATOS ATOSSA THERAPEUTICS, INC.
Nasdaq · SEC CIK 1488039 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 51 since 2021-07-07, latest 2026-05-14 18:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Daniel Mark James | CFO | — | — |
| Cigler Tessa | Dir | — | — |
| Finn Jonathan | Dir | — | — |
| Chen Shu-Chih | Dir | — | — |
| Galli Stephen J | Dir | — | — |
| Remmel H. Lawrence | Dir | — | — |
| Steinhart Richard I | Dir | — | — |
| QUAY STEVEN C | Pres, CEO, Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 18:32 | 2026-05-12 | ATOS | Steinhart Richard I | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 | |
| 2026-05-14 16:27 | 2026-05-12 | ATOS | Chen Shu-Chih | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 | |
| 2026-05-14 16:26 | 2026-05-12 | ATOS | Remmel H. Lawrence | Dir | A - Grant | $0.00 | +10.0K | 10.7K | +1,464% | $0 | |
| 2026-05-14 16:25 | 2026-05-12 | ATOS | Finn Jonathan | Dir | A - Grant | $0.00 | +10.0K | 11.7K | +600% | $0 | |
| 2026-05-14 16:25 | 2026-05-12 | ATOS | Galli Stephen J | Dir | A - Grant | $0.00 | +10.0K | 10.0K | +166,667% | $0 | |
| 2026-05-14 16:24 | 2026-05-12 | ATOS | Cigler Tessa | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 | |
| 2026-03-31 | 2026-03-27 | ATOS | QUAY STEVEN C | Pres, CEO, Dir | A - Grant | $0.00 | +65.0K | 88.0K | +282% | $0 | |
| 2026-03-30 | 2026-03-26 | ATOS | Daniel Mark James | CFO | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 | |
| DA | 2026-01-30 | 2026-01-20 | ATOS | QUAY STEVEN C | Pres, CEO, Dir | A - Grant | $0.00 | +331.7K | 345.6K | +2,386% | $0 |
| D | 2026-01-22 | 2026-01-20 | ATOS | QUAY STEVEN C | Pres, CEO, Dir | A - Grant | $0.00 | +325.2K | 339.1K | +2,340% | $0 |
| 2025-05-22 | 2025-05-21 | ATOS | QUAY STEVEN C | Pres, CEO, Dir | P - Purchase | $0.88 | +11.2K | 13.9K | +423% | +$9,890 | |
| 2025-03-28 | 2025-03-26 | ATOS | Remmel H. Lawrence | Dir | P - Purchase | $0.7 | +10.0K | 10.3K | +3,891% | +$7,000 | |
| 2024-04-11 | 2024-04-10 | ATOS | Finn Jonathan | Dir | P - Purchase | $1.77 | +25.0K | 25.0K | New | +$44.2K | |
| 2023-11-17 | 2023-11-15 | ATOS | WEAVER GREGORY L | CFO, Former EVP, Dir | S - Sale | $0.65 | -50.0K | 55 | -100% | -$32.5K | |
| 2023-06-20 | 2023-06-20 | ATOS | WEAVER GREGORY L | EVP, CFO, Dir | P - Purchase | $0.97 | +50.0K | 50.1K | +90,909% | +$48.5K | |
| DM | 2021-07-07 | 2021-07-02 | ATOS | WEAVER GREGORY L | Dir | M - OptEx | $2.22 | +164.6K | 164.6K | New | +$365.3K |
| D | 2021-07-07 | 2021-07-02 | ATOS | WEAVER GREGORY L | Dir | S - Sale+OE | $5.58 | -107.5K | 0 | -100% | -$599.8K |
| D | 2021-07-07 | 2021-07-02 | ATOS | WEAVER GREGORY L | Dir | F - Tax | $6.40 | -57.1K | 107.5K | -35% | -$365.3K |
Purchase Sale Sale after option exercise All abbreviations